摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氟苯丙基溴 | 156868-84-7

中文名称
3-氟苯丙基溴
中文别名
——
英文名称
1-(3-bromopropyl)-3- fluorobenzene
英文别名
1-(3-Bromopropyl)-3-fluorobenzene
3-氟苯丙基溴化学式
CAS
156868-84-7
化学式
C9H10BrF
mdl
MFCD09744412
分子量
217.081
InChiKey
CDHMFRCDGRGHMA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    219.3±15.0 °C(Predicted)
  • 密度:
    1.390±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    应存于室温环境,避光保存,并保持干燥密封。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis of N-Glyoxyl Prolyl and Pipecolyl Amides and Thioesters and Evaluation of Their In Vitro and In Vivo Nerve Regenerative Effects
    摘要:
    The recent discovery that small molecule ligands for the peptidyl-prolyl isomerase (PPIase) FKBP12 possess powerful neuroprotective and neuroregenerative properties in vitro and in vivo suggests therapeutic utility for such compounds in neurodegenerative disease. The neurotrophic effects of these compounds are independent of the immunosuppressive pathways by which drugs such as FK506 and rapamycin operate. Previous work by ourselves and other groups exploring the structure-activity relationships (SAR) of small molecules that mimic only the FKBP binding domain portion of FK506 has focused on esters of proline and pipecolic acid. We have explored amide and thioester analogues of these earlier structures and found that they too are extremely potent in promoting recovery of lesioned dopaminergic pathways in a mouse model of Parkinson's disease. Several compounds were shown to be highly effective upon oral administration after lesioning of the dopaminergic pathway, providing further evidence of the potential clinical utility of a variety of structural classes of FKBP12 ligands.
    DOI:
    10.1021/jm010556c
  • 作为产物:
    描述:
    3-(3-氟苯基)丙酸四溴化碳dimethyl sulfide borane三苯基膦 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 36.0h, 生成 3-氟苯丙基溴
    参考文献:
    名称:
    Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity
    摘要:
    The treatment for patients with chronic obstructive pulmonary disease (COPD) usually involves a combination of anti-inflammatory and bronchodilatory drugs. We recently found that mepenzolate bromide (1) and its derivative, 3-(2-hydroxy-2, 2-diphenylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2] octane bromide (5), have both anti-inflammatory and bronchodilatory activities. We chemically modified 5 with a view to obtain derivatives with both anti-inflammatory and longer-lasting bronchodilatory activities. Among the synthesized compounds, (R)-(-)-12 ((R)-3-(2-hydroxy-2,2-diphenylacetoxy)-1-(3-phenylpropyl)-1-azoniabicyclo[ 2.2.2] octane bromide) showed the highest affinity in vitro for the human muscarinic M3 receptor (hM(3)R). Compared to 1 and 5, (R)-(-)-12 exhibited longer-lasting bronchodilatory activity and equivalent anti-inflammatory effect in mice. The long-term intratracheal administration of (R)-(-)-12 suppressed porcine pancreatic elastase-induced pulmonary emphysema in mice, whereas the same procedure with a long-acting muscarinic antagonist used clinically (tiotropium bromide) did not. These results suggest that (R)-(-)-12 might be therapeutically beneficial for use with COPD patients given the improved effects seen against both inflammatory pulmonary emphysema and airflow limitation in this animal model.
    DOI:
    10.1016/j.bmc.2019.06.016
点击查看最新优质反应信息

文献信息

  • Intramolecular Oxidative C−H Coupling for Medium-Ring Synthesis
    作者:Didier G. Pintori、Michael F. Greaney
    DOI:10.1021/ja1090854
    日期:2011.2.9
    An oxidative C-H coupling is described for medium-ring synthesis.
    描述了用于中环合成的氧化 CH 偶联。
  • Syntheses of tetrahydronaphthalenes. Part II
    作者:John J. Parlow
    DOI:10.1016/s0040-4020(01)87011-3
    日期:1994.3
    Syntheses utilizing the cyclodehydration method to prepare novel tetrahydronaphthalenes substituted with functional groups at each position of the aromatic ring and various alkyl groups at the 1-position of the non-aromatic ring are described.
    描述了利用环脱水方法的合成,以制备在芳香环的每个位置上被官能团取代并且在非芳香环的1-位上被多个烷基取代的新型四氢萘。
  • Potential antiatherosclerotic agents. 2. (Aralkylamino)- and (alkylamino)benzoic acid analogs of cetaben
    作者:J. Donald Albright、Vern G. DeVries、Elwood E. Largis、Thomas G. Miner、Marvin F. Reich、Sheldon A. Schaffer、Robert G. Shepherd、Janis Upeslacis
    DOI:10.1021/jm00364a009
    日期:1983.10
    the corresponding esters and sodium salts, are described. The compounds were evaluated in vivo in rats for serum sterol and triglyceride lowering activity and in vitro for activity in inhibiting the principle cholesterol-esterifying enzyme of the arterial wall, fatty acyl-CoA:cholesterol acyltransferase (ACAT). Based on a combination of these two activities, cataben sodium (150) was selected for development
    描述了一系列(芳烷基氨基)-和(烷基氨基)苯甲酸的合成,以及相应的酯和钠盐。在大鼠体内评估了该化合物的血清甾醇和甘油三酸酯降低活性,并且在体外评估了该化合物在抑制动脉壁的主要胆固醇酯化酶,脂肪酰基-CoA:胆固醇酰基转移酶(ACAT)中的活性。基于这两种活性的结合,选择了卡本苯甲酸钠(150)作为降血脂药和潜在的抗动脉粥样硬化药物开发。
  • 4-Alkyloxyimino Derivatives of Uridine-5′-triphosphate: Distal Modification of Potent Agonists as a Strategy for Molecular Probes of P2Y<sub>2</sub>, P2Y<sub>4</sub>, and P2Y<sub>6</sub> Receptors
    作者:P. Suresh Jayasekara、Matthew O. Barrett、Christopher B. Ball、Kyle A. Brown、Eva Hammes、Ramachandran Balasubramanian、T. Kendall Harden、Kenneth A. Jacobson
    DOI:10.1021/jm500367e
    日期:2014.5.8
    Extended N4-(3-arylpropyl)oxy derivatives of uridine-5-triphosphate were synthesized and potently stimulated phospholipase C stimulation in astrocytoma cells expressing G protein-coupled human (h) P2Y receptors (P2YRs) activated by UTP (P2Y2/4R) or UDP (P2Y6R). The potent P2Y4R-selective N4-(3-phenylpropyl)oxy agonist was phenyl ring-substituted or replaced with terminal heterocyclic or naphthyl rings
    合成了尿苷-5'-三磷酸的扩展N 4 -(3-芳基丙基)氧基衍生物,并在星形细胞瘤细胞中有效刺激磷脂酶 C 刺激,该细胞表达 G 蛋白偶联的人 (h) P2Y 受体 (P2YRs),由 UTP (P2Y 2/ 4 R) 或 UDP (P2Y 6 R)。有效的 P2Y 4 R-选择性N 4 -(3-苯基丙基)氧基激动剂被苯环取代或被末端杂环或萘基环取代,同时保留了 P2YR 效力。对于两个核碱基均被取代的二核苷四磷酸激动剂,未观察到对远端区域空间位阻的这种广泛耐受性。有效的N 4 -(3-(4-甲氧基苯基)-丙基)氧基类似物19 (EC 50 : P2Y 2 R, 47 nM; P2Y 4 R, 23 nM) 被功能化用于链延伸,使用荧光团的点击束缚作为辅基。的BODIPY 630/650缀合物28(MRS4162)显示出EC 50个的70值,66,和23 nM的在hP2Y 2/4/6分别Rs时,和特异性标记细胞中表达P2Y
  • Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
    申请人:Aventis Pharma S.A.
    公开号:US06403610B1
    公开(公告)日:2002-06-11
    Quinolylpropylpiperidine derivatives of formula (I) which are particularly advantageous antimicrobial agents, their compositions, and their use.
    配方(I)的喹诺啉丙基哌啶衍生物,特别有优势的抗微生物药剂,其组成成分和用途。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐